Target & Activity
| Target | Activity | Value |
|---|---|---|
| Estrogen receptor | ||
| HSP90 |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| 518A2 | IC50 | 7.62 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 22749392] |
| A2058 | EC50 | 12.5 μM | Antiproliferative activity against human A2058 cells assessed as reduction in cell viability measured after 24 hrs by celltiter-blue assay | [PMID: 31099568] |
| A253 cell line | IC50 | 8.92 μM | Cytotoxicity against human A253 cells after 96 hrs by SRB assay | [PMID: 22749392] |
| A2780 | GI50 | 30.3 μM | Cytotoxicity against human A2780 cells assessed as cell growth inhibition after 72 hrs by MTS assay | [PMID: 27128175] |
| A2780 | IC50 | 7.77 μM | Cytotoxicity against human A2780 cells after 96 hrs by SRB assay | [PMID: 22749392] |
| A-431 | IC50 | > 100 μM | Cytotoxicity against human A431 cells preincubated for 4 hrs followed by incubation in compound free media for 24 hrs by MTT assay | [PMID: 29605808] |
| A549 | IC50 | 1.86 μg/mL | Cytotoxicity against human A549 cells by alamar blue assay | [PMID: 11720540] |
| A549 | IC50 | 10.08 μM | Antiproliferative activity against human A549 cells assessed as inhibition of cell growth measured after 48 hrs by SRB assay | [PMID: 31884407] |
| A549 | IC50 | 10.87 μM | Antiproliferative activity against human A549 cells by MTT assay | [PMID: 31546197] |
| A549 | IC50 | 12 μM | Antiproliferative activity against human A549 cells after 48 hrs by MTT assay | [PMID: 23287057] |
| A549 | IC50 | 17.3 μM | Cytotoxicity against human A549 cells preincubated for 4 hrs followed by incubation in compound free media for 24 hrs by MTT assay | [PMID: 29605808] |
| A549 | IC50 | 17.3 μM | Anticancer activity against human A549 cells measured after 48 hrs by SRB assay | [PMID: 27671497] |
| A549 | GI50 | 24.4 μM | Anti-proliferative activity against human A549 cells incubated for 48 hrs by SRB assay | [PMID: 26163220] |
| A549 | IC50 | 8.4 μM | Cytotoxicity against human A549 cells assessed as cell viability by MTT assay | [PMID: 26079090] |
| A549 | IC50 | 9.66 μM | Cytotoxicity against human A549 cells after 96 hrs by SRB assay | [PMID: 22749392] |
| Astrocyte | IC50 | > 10 μM | Cytotoxicity against normal human astrocytes assessed as cell viability incubated for 72 hrs by WST-1 method | [PMID: 26355532] |
| B16-F10 | IC50 | 64.87 μM | Antiproliferative activity mouse B16F10 cells after 2 days by MTT assay | [PMID: 25222876] |
| CHO | IC50 | > 100 μM | Antiproliferative activity against CHO cells after 2 days by MTT assay | [PMID: 25222876] |
| DLD-1 | IC50 | 11.06 μM | Anticancer activity against human DLD1 cells measured after 48 hrs by SRB assay | [PMID: 27671497] |
| DLD-1 | IC50 | 16.3 μM | Cytotoxicity against human DLD1 cells preincubated for 4 hrs followed by incubation in compound free media for 24 hrs by MTT assay | [PMID: 29605808] |
20 records · Scroll to view more